Log in

Relevant bibliographies by topics / Flufenamic acid / Journal articles

To see the other types of publications on this topic, follow the link: Flufenamic acid.

Journal articles on the topic 'Flufenamic acid'

Author: Grafiati

Published: 4 June 2021

Last updated: 5 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Flufenamic acid.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

&NA;. "Etofenamate/flufenamic acid." Reactions Weekly &NA;, no. 676 (1997): 8. http://dx.doi.org/10.2165/00128415-199706760-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Fatima, Rabab, Mousmee Sharma, and Parteek Prasher. "Targeted delivery of flufenamic acid by V-amylose." Therapeutic Delivery 12, no. 8 (2021): 575–82. http://dx.doi.org/10.4155/tde-2021-0020.

Full text

Abstract:

Aim: Controlled release of flufenamic acid by helical V-amylose to achieve enzyme-responsive, targeted release of the cargo drug. Materials & methods: Solid-state cross-polarization magic angle spinning carbon-13 nuclear magnetic resonance (CP/MAS NMR), Fourier transform IR and x-ray diffraction (XRD) analysis validated the entrapment of flufenamic acid inside the helical structure of V-amylose. Scanning electron microscopy (SEM) investigations established the morphology of conjugates in simulated gastric environment (pH 1.2) and simulated intestine media (pH 7.2) containing hydrolyzing en

APA, Harvard, Vancouver, ISO, and other styles

3

Farrugia, G., S. Nitecki, G. J. Harty, M. Camilleri, and J. H. Szurszewski. "The effect of flufenamic acid on gastrointestinal myoelectrical activity and transit time in dogs." Gut 42, no. 2 (1998): 258–65. http://dx.doi.org/10.1136/gut.42.2.258.

Full text

Abstract:

Background—Flufenamic acid, a fenamate, has been shown to alter markedly the membrane potential of small intestinal smooth muscle and increase intracellular calcium in single cells.Aims—To determine the effects of flufenamic acid on myoelectrical motor activity and gastrointestinal transit in the intact animal.Methods—Myoelectrical motor activity was recorded via seromuscular platinum electrodes sutured at regular intervals in the stomach and throughout the small intestine. Fasted and fed gastrointestinal transit was assessed using technetium-99m (99mTc) as the radioactive marker linked to 1 m

APA, Harvard, Vancouver, ISO, and other styles

4

Carasso, Ralph L., Odead Peled, and Shlomo Yehuda. "Flufenamic Acid in Prostaglandin Migraine." International Journal of Neuroscience 27, no. 1-2 (1985): 67–71. http://dx.doi.org/10.3109/00207458509149135.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Salem, H., and A. A. Kheir. "Atomic Absorption Spectrometry of Flufenamic Acid." Analytical Letters 28, no. 10 (1995): 1833–43. http://dx.doi.org/10.1080/00032719508000361.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Zhu, X. Y., N. Y. Li, and Z. Y. Song. "The effect of flufenamic acid on arachidonic acid metabolism." European Journal of Pharmacology 183, no. 6 (1990): 2250–51. http://dx.doi.org/10.1016/0014-2999(90)93790-w.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

GE, RUILIANG, LEI HU, YILIN TAI, et al. "Flufenamic acid promotes angiogenesis through AMPK activation." International Journal of Oncology 42, no. 6 (2013): 1945–50. http://dx.doi.org/10.3892/ijo.2013.1891.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Guinamard, Romain, Christophe Simard, and Christopher Del Negro. "Flufenamic acid as an ion channel modulator." Pharmacology & Therapeutics 138, no. 2 (2013): 272–84. http://dx.doi.org/10.1016/j.pharmthera.2013.01.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Salem, Hesham, Magda El-Maamli, and Abdalla Shalaby. "Atomic Absorption Spectrometry of Acidic Pharmaceutical Constituents by Precipitation Using Co (II), Cd (II) and Mn (II)." Scientia Pharmaceutica 68, no. 4 (2000): 343–55. http://dx.doi.org/10.3797/scipharm.aut-00-32.

Full text

Abstract:

Simple and accurate methods are described for the quantitative determination of flufenamic acid, mefenamic acid and tranexamic acid utilizing precipitation reactions with cobalt, cadmium and manganese. The acidic drugs were precipitated from their neutral alcoholic solutions with cobalt sulphate, cadmium nitrate or manganese chloride standard solutions followed by direct determination of the ions in the precipitate or indirect determination of the ions in the filtrate by atomic absorption spectroscopy. The optimum conditions for precipitation were carefully studied. The molar ratio of the reac

APA, Harvard, Vancouver, ISO, and other styles

10

Zhang, Keke, Noalle Fellah, Vilmalí López-Mejías, and Michael D. Ward. "Polymorphic Phase Transformation Pathways under Nanoconfinement: Flufenamic Acid." Crystal Growth & Design 20, no. 11 (2020): 7098–103. http://dx.doi.org/10.1021/acs.cgd.0c01207.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Senior, Kathryn. "Flufenamic acid shows promise as an epilepsy drug." Nature Reviews Neurology 5, no. 11 (2009): 577. http://dx.doi.org/10.1038/nrneurol.2009.169.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Malinovskaja-Gomez, K., H. I. Labouta, M. Schneider, J. Hirvonen, and T. Laaksonen. "Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles." European Journal of Pharmaceutical Sciences 89 (June 2016): 154–62. http://dx.doi.org/10.1016/j.ejps.2016.04.034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Lee, Yonghyun, In Ho Kim, Jeongyun Kim, et al. "Evaluation of dextran-flufenamic acid ester as a polymeric colon-specific prodrug of flufenamic acid, an anti-inflammatory drug, for chronotherapy." Journal of Drug Targeting 19, no. 5 (2010): 336–43. http://dx.doi.org/10.3109/1061186x.2010.499462.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Greenberg, S. G., J. N. Lorenz, X. R. He, J. B. Schnermann, and J. P. Briggs. "Effect of prostaglandin synthesis inhibition on macula densa-stimulated renin secretion." American Journal of Physiology-Renal Physiology 265, no. 4 (1993): F578—F583. http://dx.doi.org/10.1152/ajprenal.1993.265.4.f578.

Full text

Abstract:

The purpose of the present studies was to evaluate directly the role of prostaglandins in macula densa-mediated renin release. Individual juxtaglomerular apparatus specimens were microdissected from rabbit kidney and perfused with a solution containing either high NaCl (Na+ = 141 meq/l; Cl- = 122 meq/l) or low NaCl (Na+ = 26 meq/l; Cl- = 7 meq/l) concentration. With a step decrease in perfusate NaCl (high to low), renin secretion rate was markedly stimulated (from 15.06 to 63.1 nGU/min, P < 0.01), and the response was almost fully reversible. When specimens were bathed with cyclooxygenase i

APA, Harvard, Vancouver, ISO, and other styles

15

Sabry, Suzy M., and Hoda Mahgoub. "Voltammetric, spectrofluorimetric and spectrophotometric methods to determine flufenamic acid." Journal of Pharmaceutical and Biomedical Analysis 21, no. 5 (1999): 993–1001. http://dx.doi.org/10.1016/s0731-7085(99)00217-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Madhavan, Meenu, and Georage Chiaw-Chi Hwang. "Design and evaluation of transdermal flufenamic acid delivery system." Drug Development and Industrial Pharmacy 18, no. 5 (1992): 617–26. http://dx.doi.org/10.3109/03639049209043714.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Montoro, J., M. Rodriguez-Serna, J. J. Liñana, M. A. Ferré, and J. M. Sanchez-Motilla. "Photoallergic contact dermatitis due to flufenamic acid and etofenamate." Contact Dermatitis 37, no. 3 (1997): 139–40. http://dx.doi.org/10.1111/j.1600-0536.1997.tb00332.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Tarushi, Alketa, Philippos Kastanias, Catherine P. Raptopoulou, et al. "Zinc complexes of flufenamic acid: Characterization and biological evaluation." Journal of Inorganic Biochemistry 163 (October 2016): 332–45. http://dx.doi.org/10.1016/j.jinorgbio.2016.04.023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

TOMITA, Kazuhisa, and Takehito TAKANO. "Interaction of flufenamic Acid on Ethanol Metabolism in Rat." INDUSTRIAL HEALTH 30, no. 2 (1992): 85–95. http://dx.doi.org/10.2486/indhealth.30.85.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Sallada, Nathanael, Yongjun Li, Bryan Berger, and Matthew S. Lamm. "Engineered Hydrophobin as a Crystallization Inhibitor for Flufenamic Acid." ACS Applied Bio Materials 4, no. 8 (2021): 6441–50. http://dx.doi.org/10.1021/acsabm.1c00612.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Lyall, Vijay, Hampton Pasley, Tam-Hao T. Phan, et al. "Intracellular pH Modulates Taste Receptor Cell Volume and the Phasic Part of the Chorda Tympani Response to Acids." Journal of General Physiology 127, no. 1 (2005): 15–34. http://dx.doi.org/10.1085/jgp.200509384.

Full text

Abstract:

The relationship between cell volume and the neural response to acidic stimuli was investigated by simultaneous measurements of intracellular pH (pHi) and cell volume in polarized fungiform taste receptor cells (TRCs) using 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF) in vitro and by rat chorda tympani (CT) nerve recordings in vivo. CT responses to HCl and CO2 were recorded in the presence of 1 M mannitol and specific probes for filamentous (F) actin (phalloidin) and monomeric (G) actin (cytochalasin B) under lingual voltage clamp. Acidic stimuli reversibly decrease TRC pHi

APA, Harvard, Vancouver, ISO, and other styles

22

Mantas, Athanasios, and Albert Mihranyan. "Dissolution Behavior of Flufenamic Acid in Heated Mixtures with Nanocellulose." Molecules 25, no. 6 (2020): 1277. http://dx.doi.org/10.3390/molecules25061277.

Full text

Abstract:

Flufenamic acid (FFA) is a problem drug that has up to eight different polymorphs and shows poor solubility. Variability in bioavailability has been reported in the past resulting in limited use of FFA in the oral solid dosage form. The goal of this article was to investigate the polymorphism and amorphization behavior of FFA in non-heated and heated mixtures with high surface area nanocellulose, i.e., Cladophora cellulose (CLAD). As a benchmark, low surface area microcrystalline cellulose (MCC) was used. The solid-state properties of mixtures were characterized with X-ray diffraction, Fourier

APA, Harvard, Vancouver, ISO, and other styles

23

Delaney, Sean P., Tiffany M. Smith, and Timothy M. Korter. "Conformational origins of polymorphism in two forms of flufenamic acid." Journal of Molecular Structure 1078 (December 2014): 83–89. http://dx.doi.org/10.1016/j.molstruc.2014.02.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Pr̆iborský, J., K. Takayama, E. Mühlbachová, and T. Nagai. "Effect of penetration enhancers on percutaneous absorption of flufenamic acid." European Journal of Pharmacology 183, no. 2 (1990): 385. http://dx.doi.org/10.1016/0014-2999(90)93262-o.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Luengo, J., B. Weiss, M. Schneider, et al. "Influence of Nanoencapsulation on Human Skin Transport of Flufenamic Acid." Skin Pharmacology and Physiology 19, no. 4 (2006): 190–97. http://dx.doi.org/10.1159/000093114.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Lee, Bong-Seop, Chi Woo Yoon, Arsen Osipov, et al. "Nanoprodrugs of NSAIDs: Preparation and Characterization of Flufenamic Acid Nanoprodrugs." Journal of Drug Delivery 2011 (April 5, 2011): 1–13. http://dx.doi.org/10.1155/2011/980720.

Full text

Abstract:

We demonstrated that hydrophobic derivatives of the nonsteroidal anti-inflammatory drug (NSAID)flufenamic acid (FA), can be formed into stable nanometer-sized prodrugs (nanoprodrugs) that inhibit the growth of glioma cells, suggesting their potential application as anticancer agent. We synthesized highly hydrophobic monomeric and dimeric prodrugs of FA via esterification and prepared nanoprodrugs using spontaneous emulsification mechanism. The nanoprodrugs were in the size range of 120 to 140 nm and physicochemically stable upon long-term storage as aqueous suspension, which is attributed to t

APA, Harvard, Vancouver, ISO, and other styles

27

Dannhardt, G., S. Laufer, and M. Lehr. "HPLC determination of etofenamate and flufenamic acid in biological material." Clinical Chemistry 34, no. 12 (1988): 2580–81. http://dx.doi.org/10.1093/clinchem/34.12.2580.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Hill, K., C. D. Benham, S. McNulty, and A. D. Randall. "Flufenamic acid is a pH-dependent antagonist of TRPM2 channels." Neuropharmacology 47, no. 3 (2004): 450–60. http://dx.doi.org/10.1016/j.neuropharm.2004.04.014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

McNAMEE, PAULINE, ANTHONY MARKHAM, and ALAN J. SWEETMAN. "Flufenamic acid promotes the release of Ca2+ from isolated mitochondria." Biochemical Society Transactions 13, no. 1 (1985): 228. http://dx.doi.org/10.1042/bst0130228.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

MIYAMORI, Isamu, Takeshi SAKAI, Toshiyuki ITO, et al. "Reversible hyperkalemia induced by flufenamic acid in asymptomatic hyporeninemic patient." Japanese Journal of Medicine 24, no. 3 (1985): 269–72. http://dx.doi.org/10.2169/internalmedicine1962.24.269.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Rubio, L., G. Rodríguez, C. Alonso, et al. "Structural effects of flufenamic acid in DPPC/DHPC bicellar systems." Soft Matter 7, no. 18 (2011): 8488. http://dx.doi.org/10.1039/c1sm05692a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Wang, Yong, and M. Cathleen Kuehl-Kovarik. "Flufenamic acid modulates multiple currents in gonadotropin-releasing hormone neurons." Brain Research 1353 (September 2010): 94–105. http://dx.doi.org/10.1016/j.brainres.2010.07.047.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Hendriks, Christine M. M., Trevor M. Penning, Tianzhu Zang, et al. "Pentafluorosulfanyl-containing flufenamic acid analogs: Syntheses, properties and biological activities." Bioorganic & Medicinal Chemistry Letters 25, no. 20 (2015): 4437–40. http://dx.doi.org/10.1016/j.bmcl.2015.09.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Cerretani, D., L. Micheli, A. I. Fiaschi, and G. Giorgi. "High-performance liquid chromatography of flufenamic acid in rat plasma." Journal of Chromatography B: Biomedical Sciences and Applications 678, no. 2 (1996): 365–68. http://dx.doi.org/10.1016/0378-4347(95)00518-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

ALMEIDA, Maria Rosário, Bárbara MACEDO, Isabel CARDOSO, et al. "Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative." Biochemical Journal 381, no. 2 (2004): 351–56. http://dx.doi.org/10.1042/bj20040011.

Full text

Abstract:

In familial amyloidotic polyneuropathy, TTR (transthyretin) variants are deposited as amyloid fibrils. It is thought that this process involves TTR tetramer dissociation, which leads to partially unfolded monomers that aggregate and polymerize into amyloid fibrils. This process can be counteracted by stabilization of the tetramer. Several small compounds, such as diclofenac, diflunisal and flufenamic acid, have been reported to bind to TTR in vitro, in the T4 (thyroxine) binding channel that runs through the TTR tetramer, and consequently are considered to stabilize TTR. However, if these agen

APA, Harvard, Vancouver, ISO, and other styles

36

Lee, Eun Hee, and Stephen R. Byrn. "Stabilization of Metastable Flufenamic Acid by Inclusion of Mefenamic Acid: Solid Solution or Epilayer?" Journal of Pharmaceutical Sciences 99, no. 9 (2010): 4013–22. http://dx.doi.org/10.1002/jps.22250.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Alshehri, Sultan, Faiyaz Shakeel, Mohamed Ibrahim, et al. "Influence of the microwave technology on solid dispersions of mefenamic acid and flufenamic acid." PLOS ONE 12, no. 7 (2017): e0182011. http://dx.doi.org/10.1371/journal.pone.0182011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Tsai, Cheng-Chou, Ho-mu Lin, and Ming-Jer Lee. "Phase equilibrium and micronization for flufenamic acid with supercritical carbon dioxide." Journal of the Taiwan Institute of Chemical Engineers 72 (March 2017): 19–28. http://dx.doi.org/10.1016/j.jtice.2017.01.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Féau, Clémentine, Leggy A. Arnold, Aaron Kosinski, Fangyi Zhu, Michele Connelly, and R. Kiplin Guy. "Novel Flufenamic Acid Analogues as Inhibitors of Androgen Receptor Mediated Transcription." ACS Chemical Biology 4, no. 10 (2009): 834–43. http://dx.doi.org/10.1021/cb900143a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Rafqah, Salah, and Mohamed Sarakha. "Photochemical transformation of flufenamic acid by artificial sunlight in aqueous solutions." Journal of Photochemistry and Photobiology A: Chemistry 316 (February 2016): 1–6. http://dx.doi.org/10.1016/j.jphotochem.2015.10.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Delaney, Sean P., and Timothy M. Korter. "Terahertz Spectroscopy and Computational Investigation of the Flufenamic Acid/Nicotinamide Cocrystal." Journal of Physical Chemistry A 119, no. 13 (2015): 3269–76. http://dx.doi.org/10.1021/jp5125519.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Guo, Minshan, Ke Wang, Noel Hamill, Keith Lorimer, and Mingzhong Li. "Investigating the Influence of Polymers on Supersaturated Flufenamic Acid Cocrystal Solutions." Molecular Pharmaceutics 13, no. 9 (2016): 3292–307. http://dx.doi.org/10.1021/acs.molpharmaceut.6b00612.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

&NA;. "Topical naproxen is preferred to flufenamic acid for soft tissue injuries." Inpharma Weekly &NA;, no. 770 (1991): 10. http://dx.doi.org/10.2165/00128413-199107700-00031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Jiang, Qiannan, Zhenzhen Chen, and Hong Jiang. "Flufenamic acid alleviates sepsis‐induced lung injury by up‐regulating CBR1." Drug Development Research 81, no. 7 (2020): 885–92. http://dx.doi.org/10.1002/ddr.21706.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

ITAI, SHIGERU, MASAMI NEMOTO, SHOZO KOUCHIWA, HIROSHI MURAYAMA, and TSUNEJI NAGAI. "Influence of wetting factors on the dissolution behavior of flufenamic acid." CHEMICAL & PHARMACEUTICAL BULLETIN 33, no. 12 (1985): 5464–73. http://dx.doi.org/10.1248/cpb.33.5464.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Chavez-Dozal, Alba A., Maximillian Jahng, Hallie S. Rane, et al. "In vitro analysis of flufenamic acid activity against Candida albicans biofilms." International Journal of Antimicrobial Agents 43, no. 1 (2014): 86–91. http://dx.doi.org/10.1016/j.ijantimicag.2013.08.018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Albero, M. I., C. Sanchez-Pedreño, and M. S. Garcia. "Flow-injection spectrofluorimetric determination of flufenamic and mefenamic acid in pharmaceuticals." Journal of Pharmaceutical and Biomedical Analysis 13, no. 9 (1995): 1113–17. http://dx.doi.org/10.1016/0731-7085(95)01519-q.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Allafchian, Alireza, Hassan Hosseini, and Seyyed Mohammad Ghoreishi. "Electrospinning of PVA-carboxymethyl cellulose nanofibers for flufenamic acid drug delivery." International Journal of Biological Macromolecules 163 (November 2020): 1780–86. http://dx.doi.org/10.1016/j.ijbiomac.2020.09.129.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Kokulnathan, Thangavelu, Tzyy-Jiann Wang, Elumalai Ashok Kumar, and Zhe-Yuan Liu. "Zinc Manganate: Synthesis, Characterization, and Electrochemical Application toward Flufenamic Acid Detection." Inorganic Chemistry 60, no. 7 (2021): 4723–32. http://dx.doi.org/10.1021/acs.inorgchem.0c03672.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Nickell, William T., Nancy K. Kleene, Robert C. Gesteland, and Steven J. Kleene. "Neuronal Chloride Accumulation in Olfactory Epithelium of Mice Lacking NKCC1." Journal of Neurophysiology 95, no. 3 (2006): 2003–6. http://dx.doi.org/10.1152/jn.00962.2005.

Full text

Abstract:

When stimulated with odorants, olfactory receptor neurons (ORNs) produce a depolarizing receptor current. In isolated ORNs, much of this current is caused by an efflux of Cl−. This implies that the neurons have one or more mechanisms for accumulating cytoplasmic Cl− at rest. Whether odors activate an efflux of Cl− in intact olfactory epithelium, where the ionic environment is poorly characterized, has not been previously determined. In mouse olfactory epithelium, we found that >80% of the summated electrical response to odors is blocked by niflumic acid or flufenamic acid, each of which inh

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!